除颤器市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

Defibrillators Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年01月02日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2024 年全球除颤器市场规模将达到 136 亿美元，预计 2025 年至 2034 年期间复合年增长率将达到 5.4%。这一稳定增长主要得益于心血管疾病发病率不断上升、人们对救生医疗设备认识不断提高以及全球人口老化。由于心臟相关疾病仍然是全球主要死亡原因之一，对除颤器的需求持续上升。此外，包括自动体外心臟去颤器 (AED) 和植入式心臟復律去颤器 (ICD) 的发展在内的技术进步，使得这些救生设备更加有效、更用户友好。尤其是 AED，越来越被视为公共卫生计画中的重要工具，越来越多的公共场所和医疗设施配备了这些设备。政府的政策和措施也推动了这一趋势，这些政策和措施旨在改善基本救生设备的获取，最终缩短对心臟骤停和其他心臟相关紧急情况的反应时间。

除颤器市场根据产品类型进行细分，包括植入式心臟復律去颤器 (ICD) 和外部心臟復律去颤器。 ICD 旨在持续监测心律并在必要时发出电击以防止心臟骤停，预计在预测期内的复合年增长率为 5.2%。到 2034 年，该领域预计将创造 167 亿美元的市场价值。 ICD 的广泛应用，特别是在高风险患者群体和临床环境中，凸显了其在拯救生命方面的关键作用。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	136亿美元
预测值	238亿美元
复合年增长率	5.4%

从终端用户来看，医院在除颤器市场占据主导地位，2024 年占 67.8% 的份额。医院仍然是急救和重症监护的主要场所，先进的除颤器设备对于快速应对心臟紧急情况是必不可少的。训练有素的医疗专业人员的存在进一步推动了这些环境中除颤器的采用。此外，其他医疗机构，如门诊手术中心，也正在增加对这些救生技术的投资，促进市场的更广泛成长。

在美国，除颤器市场在 2024 年创造了 46 亿美元的收入，预计到 2034 年将以 4.5% 的复合年增长率成长。美国受益于强大的医疗保健基础设施、对医疗技术的大量投资以及鼓励广泛使用除颤器的支持性政策。公共和私营部门的倡议正在推动将 AED 整合到公共场所和医疗设施中，最终透过提高对心臟骤停的紧急响应速度和效率来提高存活率。

产业生态系统分析
产业衝击力
- 成长动力
  - 心臟病盛行率上升
  - 技术进步与创新设备的引进
  - 提高大众意识
  - 穿戴式心臟復律去颤器的需求不断增加
- 产业陷阱与挑战
  - 设备成本高
  - 产品召回
成长潜力分析
监管格局
按地区进行定价分析
管道产品
启动场景
报销场景
技术格局
差距分析
波特的分析
PESTEL 分析
指示景观
- 植入式心臟復律去颤器 (ICD)
- 穿戴式体外心臟復律去颤器 (WCD)

第四章：竞争格局

介绍
公司矩阵分析
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
策略仪表板

第 5 章：市场估计与预测：按产品，2021 - 2034 年

主要趋势
植入式心臟復律去颤器 (ICD)
- 经静脉植入式心臟復律去颤器
  - 双腔 ICD
  - 单腔 ICD
- 皮下植入式心臟復律去颤器
体外心臟復律去颤器
- 手动 ED
- 自动化 ED
  - 半自动体外心臟去颤器
  - 全自动体外心臟去颤器
- 穿戴式心臟復律去颤器

第六章：市场估计与预测：依最终用途，2021 - 2034 年

主要趋势
医院
门诊手术中心
其他最终用户

第七章：市场估计与预测：按地区，2021 - 2034 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第八章：公司简介

Abbott
Amiitalia
Asahi KASEI
BIOTRONIK
Boston Scientific
BPL Medical Technologies
CU MEDICAL
MEDITECH
Medtronic
MicroPort
mindray
NIHON KOHDEN
Philips
SCHILLER
Stryker

简介目录

Product Code: 5495

The Global Defibrillators Market is expected to reach USD 13.6 billion by 2024 and is projected to grow at a robust CAGR of 5.4% from 2025 to 2034. This steady growth is largely driven by the increasing prevalence of cardiovascular diseases, growing awareness of life-saving medical devices, and an aging population worldwide. As heart-related conditions remain one of the leading causes of death globally, the demand for defibrillators continues to rise. Additionally, advancements in technology, including the development of automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs), are making these life-saving devices more effective and user-friendly. AEDs, in particular, are increasingly seen as a crucial tool in public health initiatives, with more public spaces and medical facilities being equipped with these devices. This trend is also fueled by government policies and initiatives aimed at improving access to essential life-saving devices, ultimately enhancing response times to sudden cardiac arrest and other heart-related emergencies.

The defibrillators market is segmented based on product types, including implantable cardioverter defibrillators (ICDs) and external cardioverter defibrillators. ICDs designed to continuously monitor heart rhythms and deliver shocks when necessary to prevent sudden cardiac arrest, are projected to experience a CAGR of 5.2% over the forecast period. By 2034, this segment is expected to generate a market value of USD 16.7 billion. The widespread adoption of ICDs, particularly in high-risk patient populations and clinical settings, underscores their critical role in saving lives.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$13.6 Billion
Forecast Value	$23.8 Billion
CAGR	5.4%

In terms of end users, hospitals dominate the defibrillator market, holding a substantial share of 67.8% in 2024. Hospitals remain the primary settings for emergency and critical care, where advanced defibrillator devices are indispensable for swift response to cardiac emergencies. The availability of trained medical professionals further drives the adoption of defibrillators in these environments. Additionally, other healthcare facilities, such as ambulatory surgical centers, are increasingly investing in these life-saving technologies, contributing to the broader growth of the market.

In the U.S., the defibrillators market generated USD 4.6 billion in 2024 and is expected to grow at a CAGR of 4.5% through 2034. The U.S. benefits from a strong healthcare infrastructure, substantial investments in medical technologies, and supportive policies that encourage the widespread use of defibrillators. Public and private sector initiatives are driving the integration of AEDs into public spaces and healthcare facilities, ultimately improving survival rates by enhancing the speed and efficiency of emergency responses to sudden cardiac arrest.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of cardiac diseases
  - 3.2.1.2 Technological advancements and introduction of innovative devices
  - 3.2.1.3 Increasing public awareness
  - 3.2.1.4 Increasing demand for wearable cardioverter defibrillators
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of the devices
  - 3.2.2.2 Product recall
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pricing analysis, by region
- 3.5.1 North America
- 3.5.2 Europe
- 3.5.3 Asia Pacific
- 3.5.4 Latin America
- 3.5.5 MEA
3.6 Pipeline products
3.7 Startup scenario
3.8 Reimbursement scenario
3.9 Technology landscape
3.10 Gap analysis
3.11 Porter's analysis
3.12 PESTEL analysis
3.13 Indication landscape
- 3.13.1 Implantable cardioverter defibrillators (ICDs)
- 3.13.2 Wearable external cardioverter defibrillators (WCDs)

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 Implantable cardioverter defibrillator (ICD)
- 5.2.1 Transvenous implantable cardioverter defibrillator
  - 5.2.1.1 Dual-chamber ICDs
  - 5.2.1.2 Single-chamber ICDs
- 5.2.2 Subcutaneous implantable cardioverter defibrillator
5.3 External cardioverter defibrillator
- 5.3.1 Manual ED
- 5.3.2 Automated ED
  - 5.3.2.1 Semi-automated external defibrillator
  - 5.3.2.2 Fully automated external defibrillator
- 5.3.3 Wearable cardioverter defibrillator

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Ambulatory surgical centers
6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE